Former Chief Medical Officer · Solid Biosciences Inc. (SLDB)

Jorge Quiroz

FY2019 is the first fiscal year CompBrief holds for Jorge Quiroz as a named executive officer of Solid Biosciences; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2019

$1,541,208

Salary $412,500Stock awards $0Bonus $113,400

2nd of 3 named executive officers at Solid Biosciences by FY2019 total.

3 named officers on file for Solid Biosciences, FY2019

Jorge Quiroz’s pay file — $29

  • 1 fiscal year of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Solid Biosciences’s whole pay program stands against its peers

  • Solid Biosciences’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on SLDB→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 28, 2020 (DEF 14A).

Free

Get Jorge Quiroz’s full pay file as a PDF — free

More than this page: up to 10 years of Jorge’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Jorge Quiroz compensation by year

Solid Biosciences Summary Compensation Table · the one fiscal year held
In US dollars, as Solid Biosciences reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2019
Salary$412,500
Bonus$113,400
Stock awards$0
Option awards$1,015,308
Non-equity incentive$0
Pension and deferred compensation$0
All other$0
Total$1,541,208

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Solid Biosciences Inc. DEF 14A filed April 28, 2020, accession 0001140361-20-009881, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Solid Biosciences Inc. filed document, accession 0001140361-20-009881. Every figure is read from that document and cited to the page and table it appears in. Filed April 28, 2020.

Equity holdings

unvested awards at FY2019 year-end
TypeUnvested unitsValue at year-endExercise price
RSU23,960$106,622—
RSU19,169$85,302—
Option60,000—$22.93
Option35,296—$26.23

Per the Outstanding Equity Awards at Fiscal Year-End table in Solid Biosciences Inc.'s FY2019 proxy; value at the fiscal year-end close, as the company printed it.

Solid Biosciences’s named executive officers, FY2019

as the company reported each
Named executive officerRoleFY2019 total
Ilan GanotPresident and Chief Executive Officer$3,335,929
Jorge Quiroz · this pageFormer Chief Medical Officer$1,541,208
Alvaro AmorrortuFormer Chief Operating Officer$1,523,308

The full Solid Biosciences compensation record

free company brief

This page is one person within Solid Biosciences's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Solid Biosciences's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Jorge Quiroz's compensation dossier · One-time report. No refunds.